Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Ishida

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Biochemical and Biophysical Research Communications|October 22, 2013
A novel TK-NOG based humanized mouse model for the study of HBV and HCV infectionsKeiichi Kosaka, Nobuhiko Hiraga, Michio Imamura, et al.
Hepatology (Baltimore, Md.)|March 10, 2023
HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric miceTakuro Uchida, Michio Imamura, C Nelson Hayes, et al.
The Journal of General Virology|June 15, 2019
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized miceMitsutaka Osawa, Takuro Uchida, Michio Imamura, et al.
Biochemical and Biophysical Research Communications|May 1, 2021
Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted miceKazuki Ohya, Michio Imamura, Yuji Teraoka, et al.
Iscience|May 20, 2021
Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver diseaseYuchang Li, Liting Chen, Lu Li, et al.
Biomedical Research (Tokyo, Japan)|August 23, 2016
Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patientsKen Yamaguchi, Kenichi Urakami, Takeshi Nagashima, et al.
Cancer Science|December 22, 2019
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patientsTakeshi Nagashima, Ken Yamaguchi, Kenichi Urakami, et al.
Molecular and Clinical Oncology|October 11, 2021
Identification of tumor microenvironment-associated immunological genes as potent prognostic markers in the cancer genome analysis project HOPERyota Kondou, Yasuto Akiyama, Akira Iizuka, et al.
Cancer Treatment Reviews|May 13, 2021
Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO GuidelinesMasashi Mizumoto, Hiroshi Fuji, Mitsuru Miyachi, et al.
Scientific Reports|October 12, 2024
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genomeTakeshi Nagashima, Ken Yamaguchi, Kenichi Urakami, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Biochemical and Biophysical Research Communications|October 22, 2013
A novel TK-NOG based humanized mouse model for the study of HBV and HCV infectionsKeiichi Kosaka, Nobuhiko Hiraga, Michio Imamura, et al.
Hepatology (Baltimore, Md.)|March 10, 2023
HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric miceTakuro Uchida, Michio Imamura, C Nelson Hayes, et al.
The Journal of General Virology|June 15, 2019
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized miceMitsutaka Osawa, Takuro Uchida, Michio Imamura, et al.
Biochemical and Biophysical Research Communications|May 1, 2021
Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted miceKazuki Ohya, Michio Imamura, Yuji Teraoka, et al.
Iscience|May 20, 2021
Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver diseaseYuchang Li, Liting Chen, Lu Li, et al.
Biomedical Research (Tokyo, Japan)|August 23, 2016
Prevalence of low-penetrant germline TP53 D49H mutation in Japanese cancer patientsKen Yamaguchi, Kenichi Urakami, Takeshi Nagashima, et al.
Cancer Science|December 22, 2019
Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patientsTakeshi Nagashima, Ken Yamaguchi, Kenichi Urakami, et al.
Molecular and Clinical Oncology|October 11, 2021
Identification of tumor microenvironment-associated immunological genes as potent prognostic markers in the cancer genome analysis project HOPERyota Kondou, Yasuto Akiyama, Akira Iizuka, et al.
Cancer Treatment Reviews|May 13, 2021
Proton beam therapy for children and adolescents and young adults (AYAs): JASTRO and JSPHO GuidelinesMasashi Mizumoto, Hiroshi Fuji, Mitsuru Miyachi, et al.
Scientific Reports|October 12, 2024
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genomeTakeshi Nagashima, Ken Yamaguchi, Kenichi Urakami, et al.
Pageof 20